Metabiomics
Press Releases
Metabiomics and Chinese Health Testing Leader Kindstar Global form Partnership to Develop a Microbiome and Next-Generation Sequencing-Based Screening Test for Colorectal Cancer
Metabiomics and Kindstar Global, a leading specialty clinical testing laboratory in China, have signed a licensing and distribution deal for the development of the world’s first microbiome-based screening test for colon polyps and colorectal cancer.
Metabiomics Selected to Present a Next-Generation Sequencing Cancer Diagnostics Strategy at Two Upcoming Investor Conferences
Metabiomics, an early stage molecular diagnostics firm, will visit Denver, Colorado and Orange County, California next week to present a business plan and growth strategy for commercializing a non-invasive screening test for colorectal cancer.
New Metabiomics Screening Test for Early Detection and Prevention of Colorectal Cancer Poised to Reduce Health Care Costs and Save Lives
Metabiomics Selected to Present Molecular Diagnostic Innovations and Growth Strategy at Annual Mid-Atlantic BIO Conference Potomac Falls, Virginia (September 17, 2012) Metabiomics, a Northern-VA-based molecular diagnostics firm, was selected by the Mid-Atlantic Bio...
Microbiome Biomarker and Diagnostic Patent Awarded by EPO
Metabiomics® announced today that it has been awarded patent number EP 1815016 B1 titled “Compositions and Methods for Diagnosing Colon Disorders” by the European Patent Office (EPO).
New Health Sciences Frontiers in Metagenomics and the Human Microbiome
It is not often that health sciences takes off in leaps and bounds on a whole new branch of discovery. Systems Biology scientists are exploring the Metagenome and Microbiome of Humans to map their interactive genetic and metabolic functions.We define the complex...
MultiTag Sequencing™ Services Now Available for Genomics Research Applications
Manassas, VA (April 15, 2009) -- Metabiomics© is now offering the human Genomics research community advanced MultiTag Sequencing™ primers and services including a limited license to use its patent pending MultiTag Sequencing™ method for research purposes. This...
Metabiomics Awarded Qualifying Therapeutic Discovery Project Grant
Biotechnology Grant Award Launches Metabiomics Human Microbiome Commercialization Initiative Potomac Falls, Virginia – November 5, 2010: Metabiomics, a human microbiome biomarker discovery and molecular diagnostics company, announced that that it was awarded a grant...
MultiTag Sequencing™ Patent Application Advances to National Phase
Metabiomics© announced that it received a favorable International Preliminary Report on Patentability from the Patent Cooperation Treaty (PCT) on its application to patent its enabling MultiTag Sequencing™ (MTPS) method for unique identification of multiple samples...
Breakthrough MultiTag Sequencing™ Primers and Services Now Available for Metagenomics Research
Advanced MultiTag Sequencing™ primer kits and full line of pyrosequencing services are now available from Metabiomics© to the Microbiome research community to increase throughput, productivity, and comparative statistical analysis, differentiating subject populations,...
New Microbiome Research Center Advances MultiTag Sequencing™ Technology
Manassas, VA (April 15, 2009) – The newly organized MicroBiome Analysis Center (MBAC) at George Mason University has partnered with Metabiomics to map the world that bacteria, viruses, fungi and protozoa inhabit the human body called the Human Microbiome. The MBAC has...